Inhibition of LATS Kinases in Ovarian Cancer Activates Cyclin D1/CDK4 and Decreases DYRK1A Activity
F. Sesay, S. Saini, A. Pajimola, A. Witt, B. Hu, J. Koblinski, L. Litovchick
This study shows that inhibiting LATS kinases in ovarian cancer cells activates cyclin D1/CDK4 and reduces DYRK1A activity, promoting tumor growth.
bioRxiv · Dec 6, 2022 · PreprintCancer Biology